Skip Content
You are currently on the new version of our website. Access the old version .
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 26, Issue 2

2019 April - 35 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (35)

  • Article
  • Open Access
37 Citations
3,381 Views
6 Pages

Cost-of-Illness Study for Non-Small-Cell Lung Cancer Using Real-World Data

  • S.J. Seung,
  • M. Hurry,
  • S. Hassan,
  • R.N. Walton and
  • W.K. Evans

1 April 2019

Background: With recent advances in the treatment of non-small-cell lung cancer (NSCLC) and current fiscal constraints within publicly funded health care systems, understanding the real-world economic effect of lung cancer management has become impor...

  • Article
  • Open Access
11 Citations
1,374 Views
6 Pages

Real-World Costing Analysis for Diffuse Large B-Cell Lymphoma in British Columbia

  • S. Costa,
  • D.W. Scott,
  • C. Steidl,
  • S.J. Peacock and
  • D.A. Regier

1 April 2019

Introduction: Diffuse large B-cell lymphoma (DLBCL) accounts for 30%–40% of all non-Hodgkin lymphomas. Approximately 60% of patients are cured with standard treatment. Targeted treatments are being investigated and might improve disease outcomes; how...

  • Article
  • Open Access
13 Citations
1,472 Views
5 Pages

1 April 2019

Introduction: Given the high occurrence and morbidity of non-melanoma skin cancer (NMSC), its economic burden on the Canadian health care system is a cause for concern. Despite that relevance, few studies have used patient-level data to calculate the...

  • Article
  • Open Access
112 Citations
5,127 Views
5 Pages

1 April 2019

Oropharyngeal cancer (OPC) has become the leading site for human papillomavirus (HPV)–associated cancers in humans. It is an epidemic that remains relatively unfamiliar to most physicians, potentially delaying diagnosis and treatment. Traditionally,...

  • Article
  • Open Access
11 Citations
1,531 Views
13 Pages

Are Patient Education Materials about Cancer Screening More Effective When Co-Created with Patients? A Qualitative Interview Study and Randomized Controlled Trial

  • N.Y. Bashir,
  • J.E. Moore,
  • D. Buckland,
  • M. Rodrigues,
  • M. Tonelli,
  • B.D. Thombs,
  • N.R. Bell,
  • W. Isaranuwatchai,
  • T. Peng and
  • S.E. Straus
  • + 1 author

1 April 2019

Background: Patient education materials (PEMS) are frequently used to help patients make cancer screening decisions. However, because PEM are typically developed by experts, they might inadequately address patient barriers to screening. We co-created...

  • Article
  • Open Access
12 Citations
1,536 Views
12 Pages

Patient Decision Aid for Contralateral Prophylactic Mastectomy for Use in the Consultation: A Feasibility Study

  • J.E. Squires,
  • D. Stacey,
  • M. Coughlin,
  • M. Greenough,
  • A. Roberts,
  • K. Dorrance,
  • M. Clemons,
  • J.M. Caudrelier,
  • I.D. Graham and
  • A. Arnaout
  • + 2 authors

1 April 2019

Background: Rates of contralateral prophylactic mastectomy (CPM) continue to rise internationally despite evidence-based guidance strongly discouraging its use in most women with unilateral breast cancer. The purpose of the present study was to devel...

  • Article
  • Open Access
1 Citations
2,145 Views
7 Pages

A Network Approach to Developing Immuno-Oncology Combinations in Canada

  • V. Higenell,
  • R. Fajzel,
  • G. Batist,
  • P.K. Cheema,
  • H.L. McArthur,
  • B. Melosky,
  • D. Morris,
  • T.M. Petrella,
  • R. Sangha and
  • S. Verma
  • + 4 authors

1 April 2019

Immune checkpoint inhibitors have revolutionized care for many cancer indications, with considerable effort now being focused on increasing the rate, depth, and duration of patient response. One strategy is to combine immune strategies (for example,...

  • Article
  • Open Access
15 Citations
1,736 Views
5 Pages

Moving toward the Elimination of Cervical Cancer: Modelling the Health and Economic Benefits of Increasing Uptake of Human Papillomavirus Vaccines

  • A. Smith,
  • N. Baines,
  • S. Memon,
  • N. Fitzgerald,
  • J. Chadder,
  • C. Politis,
  • E. Nicholson,
  • C. Earle and
  • H. Bryant

1 April 2019

Background: The human papillomavirus (HPV) is a common sexually transmitted infection and a primary cause of cervical cancer. The Government of Canada has set a target of reaching 90% HPV vaccine coverage among adolescents by 2025. Here, we examine H...

of 4

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729